Liu S - Search Results

1

SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer.

Li K, Shu D, Li H, Lan A, Zhang W, Tan Z, Huang M, Tomasi ML, Jin A, Yu H, Shen M, Liu S. Li K, et al. Among authors: liu s. Cell Death Dis. 2024 Jun 24;15(6):444. doi: 10.1038/s41419-024-06838-9. Cell Death Dis. 2024. PMID: 38914552 Free PMC article.

2

Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis.

Yao ZX, Lu LJ, Wang RJ, Jin LB, Liu SC, Li HY, Ren GS, Wu KN, Wang DL, Kong LQ. Yao ZX, et al. Med Oncol. 2014 Jan;31(1):798. doi: 10.1007/s12032-013-0798-y. Epub 2013 Dec 5. Med Oncol. 2014. PMID: 24307349 Review.

3

Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China.

Wang RJ, Lu LJ, Jin LB, Li HY, Ren GS, Wu KN, Liu SC, Kong LQ. Wang RJ, et al. Med Oncol. 2014 Jan;31(1):788. doi: 10.1007/s12032-013-0788-0. Epub 2013 Dec 12. Med Oncol. 2014. PMID: 24338167

4

Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.

Tao K, Guo S, Chen R, Yang C, Jian L, Yu H, Liu S. Tao K, et al. Among authors: liu s. Mol Diagn Ther. 2019 Feb;23(1):127-138. doi: 10.1007/s40291-019-00384-3. Mol Diagn Ther. 2019. PMID: 30694446

5

Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.

Yu H, Yang C, Jian L, Guo S, Chen R, Li K, Qu F, Tao K, Fu Y, Luo F, Liu S. Yu H, et al. Among authors: liu s. Oncol Rep. 2019 Aug;42(2):826-838. doi: 10.3892/or.2019.7189. Epub 2019 Jun 6. Oncol Rep. 2019. PMID: 31173262

6

CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis.

Yang C, Yu H, Chen R, Tao K, Jian L, Peng M, Li X, Liu M, Liu S. Yang C, et al. Among authors: liu m, liu s. Int J Oncol. 2019 Sep;55(3):684-696. doi: 10.3892/ijo.2019.4840. Epub 2019 Jul 15. Int J Oncol. 2019. PMID: 31322183 Free PMC article.

7

Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.

Peng Y, Chen R, Qu F, Ye Y, Fu Y, Tang Z, Wang Y, Zong B, Yu H, Luo F, Liu S. Peng Y, et al. Among authors: liu s. Cancer Biol Ther. 2020;21(2):189-196. doi: 10.1080/15384047.2019.1680057. Epub 2019 Nov 4. Cancer Biol Ther. 2020. PMID: 31684807 Free PMC article.

8

Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer.

Guo S, Jian L, Tao K, Chen C, Yu H, Liu S. Guo S, et al. Among authors: liu s. Front Oncol. 2019 Dec 17;9:1325. doi: 10.3389/fonc.2019.01325. eCollection 2019. Front Oncol. 2019. PMID: 31921620 Free PMC article.

9

Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer.

Chen R, Guo S, Yang C, Sun L, Zong B, Li K, Liu L, Tu G, Liu M, Liu S. Chen R, et al. Among authors: liu m, liu l, liu s. Int J Oncol. 2020 Apr;56(4):932-944. doi: 10.3892/ijo.2020.4987. Epub 2020 Feb 14. Int J Oncol. 2020. PMID: 32319562 Free PMC article.

10

Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Qu F, Chen R, Peng Y, Ye Y, Tang Z, Wang Y, Zong B, Yu H, Liu S. Qu F, et al. Among authors: liu s. J Breast Cancer. 2020 Jun;23(3):246-258. doi: 10.4048/jbc.2020.23.e32. J Breast Cancer. 2020. PMID: 32595987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,905 results

Search Page

Filters